ADMINISTRATION OF TIKLID IN DIABETIC-RETI NOPATHY

Authors
RUBTSOVA AL AMETOV AS STRAKHOV VV
Citation
Al. Rubtsova et al., ADMINISTRATION OF TIKLID IN DIABETIC-RETI NOPATHY, Terapevticeskij arhiv, 69(10), 1997, pp. 19-21
Citations number
11
Journal title
Terapevticeskij arhiv → ACNP
ISSN journal
00403660
Volume
69
Issue
10
Year of publication
1997
Pages
19 - 21
Database
ISI
SICI code
0040-3660(1997)69:10<19:AOTIDN>2.0.ZU;2-E
Abstract
A clinical trial has been conducted of antiaggregation effects of tikl id in 100 diabetes mellitus patients with preproliferative and prolife rative retinopathy. Tiklid was found to improve blood rheology, to pro mote partial recovery of retinal function. As such effects contribute to prevention of progression of the proliferative alterations, tiklid can be recommended for treatment of preproliferative and proliferative retinopathy in patients with diabetes mellitus.